Imricor Medical Systems, Inc (IMR)

IMR Chart

vs Index S&P/ASX 20 S&P/ASX 50 S&P/ASX 100 S&P/ASX 200 S&P/ASX 300 All Ordinaries Small Ordinaries All Technology Consumer Staples Energy Financials Health Care Industrials Info Technology Materials Real Estate Comm. Services Utilities

Advanced

Show News Mov Avgs 9-day 10-day 20-day 30-day 50-day 100-day 150-day 200-day Mov Avgs 9-day 21-day 30-day 200-day Simple Exponential Weighted Simple Exponential Weighted vs Index S&P/ASX 20 S&P/ASX 50 S&P/ASX 100 S&P/ASX 200 S&P/ASX 300 All Ordinaries Small Ordinaries All Technology Consumer Staples Energy Financials Health Care Industrials Info Technology Materials Real Estate Comm. Services Utilities

Mov Avgs 10-day 20-day 30-day 50-day 100-day 150-day 200-day 9/21 Cross 10/30 Cross Golden Cross Vol RSI BB

Day 3m 6m 1yr 5yr 10yr

IMR's Principal Activity is the design, manufacture and sell MRI-compatible products for cardiac catheter ablation procedures to treat arrhythmias.

Announcements

Company Overview

Dividend History

Directors & Management

Name	Title	Since	Bio
Ms Anita Messal	Non-Executive Director	Mar 2021	Ms Anita Messal Non-Executive Director Ms Messal has 35 years of experience in the healthcare sector and is currently the Chief Integration Officer at AccentCare,Inc. a US based national post-acute healthcare provider, where she is responsible for the integration of merged and acquired entities across all areas of the business. Prior to AccentCare, she most recently served as President & Chief Operating Officer of PlanSource. In this role, she was responsible for company technology & operations including all aspects of Technology, Product, Service Delivery, Legal, and Human Resources. Ms Messal has participated in fund raising from start-up through IPO and sale to strategic buyers and private equity. She has worked in both Fortune 100 and start-up companies with experience in public, private and non-profit businesses. Her experience includes working in domestic and international markets, where she involved in developing programs and partnerships in the United Kingdom and the European Union.
Mr Peter McGregor	Non-Executive Director	May 2019	Mr Peter McGregor Non-Executive Director Mr McGregor has over 30 years' experience in senior finance and management roles, including having been a partner in the investment banking firm of Goldman Sachs JBWere and a managing director in the institutional banking & markets division of Commonwealth Bank of Australia. He is Chair of Risk Committee.
Mr Mark Tibbles	Non-Executive Director	Sep 2014	Mr Mark Tibbles Non-Executive Director Mr Tibbles is an entrepreneur, business owner, company director and active venture investor in and advisor to technology, life science and medical device companies. Mr Tibbles is currently the Managing Director of Strategic Stage Ventures, LLC and an owner and managing member of STEM Fuse. Prior to his current roles, Mr Tibbles was an owner and member of Intuitive Technology Group until it was sold in 2017. Mr Tibbles was also President and founder of PRC Consulting, Inc. from 1998 until 2013, when PRC was sold. Mr Tibbles currently serves as an independent director of OMEDZA.com, Inc. He is Member of Risk Committee.
Mr Steve Wedan	Chief Executive Officer,President,Executive Chairman,Executive Director	May 2006	Mr Steve Wedan Chief Executive Officer,President,Executive Chairman,Executive Director Mr Wedan is responsible for the overall management and strategic direction of the Company. Mr Wedan has over 29 years of experience in the medical device industry including design engineering of MRI and ultrasound systems for GE Healthcare, as well as Vice President and Chief Technology Officer for Applied Biometrics Inc. Immediately prior to co-founding Imricor, Mr Wedan founded and operated a technical consulting company, Wedan Technologies Inc., from 2000-2006. Mr Wedan is a member of various international standards committees in the fields of MRI safety and the compatibility of implanted and interventional products in MRI. Mr Wedan currently serves on the boards of Medical Device Research Forum and Water Rescue Innovations, Inc.
Mr Kobe Li	Company Secretary	N/A

Show All

Director Transactions

Date	Director	Type	Amount	Price	Value	Notes
14/05/20	Steve Wedan	Issued	579,187	$1.34	$776,110	Issue of options
14/05/20	Mark Tibbles	Issued	71,010	$1.34	$95,153	Issue of options
14/05/20	Doris Engibous	Issued	66,571	$1.34	$89,205	Issue of options
14/05/20	Peter McGregor	Issued	71,010	$1.34	$95,153	Issue of options
31/12/19	Steve Wedan	Transfer	2,518,219	$1.195	$3,009,272	Off-market transfer
31/12/19	Steve Wedan	Transfer	2,518,219	$1.195	$3,009,272	Off-market transfer
31/12/19	Mark Tibbles	Issued	2,897	$1.195	$3,462	Conversion of convertible notes
31/12/19	Steve Wedan	Issued	501	$1.195	$599	Conversion of convertible notes
24/12/19	Mark Tibbles	Buy	+30,000	$0.341	$10,230	Exercise of options
24/12/19	Mark Tibbles	Exercise	30,000	$0.341	$10,230	Exercise of options

Show All

Director Interests

Director	Last Notice	Direct Shares	Indirect Shares	Options	Convertibles
Anita Messal	01/03/2021	0	N/A	N/A	N/A
Mark Tibbles	14/05/2020	4,581,878	N/A	485,910	N/A
Steve Wedan	14/05/2020	0	4,424,232	1,839,987	N/A
Peter McGregor	14/05/2020	N/A	N/A	206,010	N/A

Show All

Top 20 Shareholders About the Data

Name	Shares	Capital
No Top 20 Shareholder Information	0	0.00%

Show All

Shareholder Distribution

As reported in the most recent Annual Report.

The most recent Annual Report didn't contain Shareholder Distribution data.

Substantial Shareholders

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

Share Price History

Date	Close	Change	%Chg	Open	High	Low	Volume	Turnover

Full Month

Historical Data

Year	Closing Price	Last Trade
2020	$1.49	30 June

IMR Historical Price Data (CSV)

Up to 20 years of EOD share price history

Sign up to Download

You must be logged in to access this feature. Please sign up for free or login.